Based on the functional impact of the Pgam5-PHB2 interaction on cardiomyocyte homeostasis, we further suggest that therapeutic strategies aiming at stimulating mitophagy and UPRmt may be useful to alleviate endotoxemia-induced cardiac injury. The gene discussed is PHB2; the disease is serum lipopolysaccharide activity.